Skip to content

Opioid Free and Therapy Minimized Advantages Using HANA Table for Total Hip Arthroplasty

Opioid Free and Therapy Minimized Advantages Using HANA Table for Total Hip Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03790306
Enrollment
207
Registered
2018-12-31
Start date
2019-01-15
Completion date
2020-03-30
Last updated
2020-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthropathy of Hip Joint, Osteoarthritis, Hip

Brief summary

To prove that anterior approach total hip arthroplasty using the HANA table can be performed with little, if any, need for opioids using a combination of education, optimized pre op and post op pain protocols and optimized recovery tools.

Detailed description

Methods: Data Collection: * pre-op assessment/physical therapy evaluation * post op assessment - PACU, phase II (Prior to discharge) * phone calls after discharge (post op day 1, 2, 3) * follow up assessment in surgeon's office (3 and 6 weeks post op) * Ortech * Swiftpath * HOOS jr Pre-optimization: * All patients enroll in SwiftPath education program * Optimized BMI, hemoglobin, albumin, glucose control, A1C and blood pressure control Total Joint procedure: -anterior approach using the HANA table THA preformed with intra-articular block Pain Management regimen: * Pre op PT teaching * post op multimodal pain regimen

Interventions

None listed

Sponsors

St. Elizabeth Medical Center, Utica, NY
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Elective total hip arthroplasty * unilateral * patient surgeries scheduled to be performed at the hospital and surgery center * patients must enroll in SwiftPath * Ability to read and understand English

Exclusion criteria

* Patient diagnosis of schizophrenia, bipolar disease, dementia * previous burn to affected extremity * BMI \> 40 * Hemoglobin \<12 female, \<13 male * Albumin less than 3.5 * A1C \>8.0

Design outcomes

Primary

MeasureTime frameDescription
Pre-operative Narcotic UsePre-operativelyPercentage of patients that used used opioids pre-operatively
Number of Patients That Took Any Opioids Throughout 6-week Follow-up Period6 weeksNumber of patients that took any opioids throughout 6-week follow-up period
Short Physical Performance Battery6 WeeksAssessment tool measuring gait speed, balance and chair stand test. Scores range from 0 to 4 with higher scores indicating a better outcome.

Secondary

MeasureTime frameDescription
Length of Stay in Hospital1 weekAverage number of days in hospital after surgery
Numeric Pain Scores6 WeeksA numeric pain score (0-10, 0 is no pain and 10 is worst imaginable pain). This will be used to assess patients level of pain relating to opioid use and recovery. Both 'best' pain level and 'worst' pain level as reported by the patient will be reported.
Number of Patients Who Return to Driving 6 Weeks After Surgery6 WeeksPatients will respond yes or no when asked if they have resumed driving.
Number of Patients That Return to Work 6 Weeks After Surgery6 weeksquestionnaire asking the patient to report whether or not they have returned to employment and at what capacity (using Department of Labor physical employment scale). Patients will answer yes or no when asked if they have returned to work.
Sleep Quality6 WeeksThe percentage of patients where pain interrupts sleep 'never' or 'rarely' will be combined together and reported.
Number of Participants Who Adhere to Prescribed Post op Recovery Protocol2 weeksNumber of Participants Who Adhere to Prescribed Post op Recovery Protocol collected via a questionnaire

Countries

United States

Participant flow

Participants by arm

ArmCount
THR With HANA Table
Patients undergoing Total Hip Replacement (THR) with use of the Hip And kNee Arthroplasty (HANA) table.
207
Total207

Baseline characteristics

CharacteristicTHR With HANA Table
Age, Continuous68.7 years
STANDARD_DEVIATION 9.75
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
202 Participants
Region of Enrollment
United States
207 participants
Sex: Female, Male
Female
116 Participants
Sex: Female, Male
Male
91 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 207
other
Total, other adverse events
0 / 207
serious
Total, serious adverse events
0 / 207

Outcome results

Primary

Number of Patients That Took Any Opioids Throughout 6-week Follow-up Period

Number of patients that took any opioids throughout 6-week follow-up period

Time frame: 6 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THR With HANA TableNumber of Patients That Took Any Opioids Throughout 6-week Follow-up Period128 Participants
Primary

Pre-operative Narcotic Use

Percentage of patients that used used opioids pre-operatively

Time frame: Pre-operatively

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THR With HANA TablePre-operative Narcotic Use30 Participants
Primary

Short Physical Performance Battery

Assessment tool measuring gait speed, balance and chair stand test. Scores range from 0 to 4 with higher scores indicating a better outcome.

Time frame: 6 Weeks

ArmMeasureGroupValue (MEAN)Dispersion
THR With HANA TableShort Physical Performance BatteryBalance3.95 score on a scaleStandard Deviation 0.31
THR With HANA TableShort Physical Performance BatteryGait3.89 score on a scaleStandard Deviation 0.45
THR With HANA TableShort Physical Performance BatteryChair3.17 score on a scaleStandard Deviation 1.31
Secondary

Length of Stay in Hospital

Average number of days in hospital after surgery

Time frame: 1 week

ArmMeasureValue (MEAN)
THR With HANA TableLength of Stay in Hospital0.4175 days
Secondary

Number of Participants Who Adhere to Prescribed Post op Recovery Protocol

Number of Participants Who Adhere to Prescribed Post op Recovery Protocol collected via a questionnaire

Time frame: 2 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THR With HANA TableNumber of Participants Who Adhere to Prescribed Post op Recovery Protocol206 Participants
Secondary

Number of Patients That Return to Work 6 Weeks After Surgery

questionnaire asking the patient to report whether or not they have returned to employment and at what capacity (using Department of Labor physical employment scale). Patients will answer yes or no when asked if they have returned to work.

Time frame: 6 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THR With HANA TableNumber of Patients That Return to Work 6 Weeks After Surgery56 Participants
Secondary

Number of Patients Who Return to Driving 6 Weeks After Surgery

Patients will respond yes or no when asked if they have resumed driving.

Time frame: 6 Weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THR With HANA TableNumber of Patients Who Return to Driving 6 Weeks After Surgery182 Participants
Secondary

Numeric Pain Scores

A numeric pain score (0-10, 0 is no pain and 10 is worst imaginable pain). This will be used to assess patients level of pain relating to opioid use and recovery. Both 'best' pain level and 'worst' pain level as reported by the patient will be reported.

Time frame: 6 Weeks

ArmMeasureGroupValue (MEAN)Dispersion
THR With HANA TableNumeric Pain ScoresBest pain level0.00966 units on a scaleStandard Deviation 0.139
THR With HANA TableNumeric Pain ScoresWorst pain level2.14 units on a scaleStandard Deviation 1.77
Secondary

Sleep Quality

The percentage of patients where pain interrupts sleep 'never' or 'rarely' will be combined together and reported.

Time frame: 6 Weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
THR With HANA TableSleep Quality184 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026